AKAP12 and prostate carcinoma: For example, SSeCKS re-expression in MAT-LyLu prostate cancer cells suppresses the formation of macroscopic lung metastases spontaneously arising from subcutaneous or orthotopic sites, without affecting primary-site tumor growth [21].